The single-cell analysis transcriptomics market size has grown rapidly in recent years. It will grow from $1.08 billion in 2025 to $1.22 billion in 2026 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to high cost of early sequencing equipment, limited accessibility of microfluidics technologies, reliance on conventional bulk tissue analysis, growing academic research funding, emerging awareness of cellular heterogeneity.
The single-cell analysis transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $1.92 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to technological advancements in single-cell sequencing platforms, integration of cloud-based bioinformatics solutions, rising investment by pharmaceutical and biotechnology companies, increased adoption in personalized medicine, expansion of hospital and diagnostic center applications. Major trends in the forecast period include increasing adoption of single-cell rna sequencing techniques, rising use of microfluidics-based platforms, expansion of clinical diagnostics applications, growth in drug discovery and development research, enhanced data analysis and bioinformatics capabilities.
The growing adoption of personalized medicine is expected to accelerate the expansion of the single-cell analysis transcriptomics market. Personalized medicine is a tailored approach to medical treatment based on an individual’s genetic profile, lifestyle, and environmental factors. The rise in personalized medicine is driven by advances in genetic sequencing, which enable treatments customized to a patient’s genetic makeup for enhanced effectiveness. Single-cell analysis transcriptomics plays a crucial role by uncovering gene expression profiles at the individual cell level, guiding the development of personalized treatments based on a patient’s unique biology. This approach improves therapeutic outcomes, reduces side effects, and supports early disease diagnosis. For instance, in February 2024, the Personalized Medicine Coalition, a US-based healthcare organization, reported that the U.S. Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, a significant increase from the six approvals in 2022. This growing trend in personalized medicine is driving the growth of the single-cell analysis transcriptomics market.
Major companies operating in the single cell analysis transcriptomics market are focusing on developing innovative products, such as single cell RNA sequencing kits, to streamline workflows and enable deeper insights into cellular heterogeneity. A single cell RNA sequencing kit is a specialized tool to isolate and analyze gene expression at the individual cell level. It allows researchers to uncover cellular diversity and gain insights into complex biological processes. For instance, in January 2024, Scale Biosciences, a US based biotechnology company specializing in single cell solutions, launched the Single Cell RNA Kit v1.1 - Extended Throughput, enabling processing of up to 500,000 cells per run under an instrument free workflow. This release significantly enhances scaling, multiplexing, and cost efficiency in transcriptomic studies.
In May 2024, Bruker Corporation, a US-based manufacturer of scientific instruments, acquired NanoString Technologies for approximately $392.6 million. This acquisition aims to integrate NanoString’s gene expression profiling and spatial transcriptomics solutions into Bruker’s expanding spatial biology portfolio. The integration of NanoString’s technology will enhance Bruker’s capabilities in discovery and translational research, positioning them as a leader in single-cell and spatial biology innovations.
Major companies operating in the single-cell analysis transcriptomics market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius Aktiengesellschaft, Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Abcam Limited, Novogene Co. Ltd., Standard BioTools Inc., Akoya Biosciences Inc., Parse Biosciences Inc., Cell Microsystems Inc., Mission Bio Inc., CYTENA GmbH, Fluent BioSciences.
North America was the largest region in the single-cell analysis transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single-cell analysis transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the single-cell analysis transcriptomics market by increasing the cost of imported sequencing equipment, reagents, and microfluidics consumables. Segments such as RNA sequencers, library preparation kits, and microarray instruments are most impacted, particularly in Asia-Pacific regions like China and India that are major import hubs. This has led to higher operational costs and supply chain challenges. On the positive side, tariffs have encouraged local manufacturing, alternative sourcing strategies, and innovation in cost-effective technologies for transcriptomics research.
The single-cell analysis transcriptomics market research report is one of a series of new reports that provides single-cell analysis transcriptomics market statistics, including single-cell analysis transcriptomics industry global market size, regional shares, competitors with a single-cell analysis transcriptomics market share, detailed single-cell analysis transcriptomics market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell analysis transcriptomics industry. This single-cell analysis transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Single-cell transcriptomics is a powerful technique that enables the study of gene expression at the individual cell level. It helps identify cellular heterogeneity and unique transcriptional profiles within complex tissues. This approach allows researchers to uncover cellular diversity, discover rare cell types, trace developmental lineages, and gain deeper insights into disease mechanisms.
The main component types of single-cell transcriptomics include equipment, consumables, software, and services. In single-cell transcriptomics, equipment is used for precise RNA analysis at the individual cell level, advancing genomic research and personalized medicine. Various technologies, such as single-cell RNA sequencing, microfluidics-based techniques, and others, are employed for applications including clinical diagnostics, developmental biology, drug discovery, and more. These tools are used by a wide range of end-users, including academic and research institutions, hospitals and diagnostic centers, and pharmaceutical and biotechnology companies.
The single-cell analysis transcriptomics market consists of revenues earned by entities by providing services such as data analysis and interpretation, sample preparation, and customized gene expression profiling solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The single-cell analysis transcriptomics market includes sales of RNA extraction kits, library preparation kits, cnd DNA synthesis kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The single-cell analysis transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $1.92 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to technological advancements in single-cell sequencing platforms, integration of cloud-based bioinformatics solutions, rising investment by pharmaceutical and biotechnology companies, increased adoption in personalized medicine, expansion of hospital and diagnostic center applications. Major trends in the forecast period include increasing adoption of single-cell rna sequencing techniques, rising use of microfluidics-based platforms, expansion of clinical diagnostics applications, growth in drug discovery and development research, enhanced data analysis and bioinformatics capabilities.
The growing adoption of personalized medicine is expected to accelerate the expansion of the single-cell analysis transcriptomics market. Personalized medicine is a tailored approach to medical treatment based on an individual’s genetic profile, lifestyle, and environmental factors. The rise in personalized medicine is driven by advances in genetic sequencing, which enable treatments customized to a patient’s genetic makeup for enhanced effectiveness. Single-cell analysis transcriptomics plays a crucial role by uncovering gene expression profiles at the individual cell level, guiding the development of personalized treatments based on a patient’s unique biology. This approach improves therapeutic outcomes, reduces side effects, and supports early disease diagnosis. For instance, in February 2024, the Personalized Medicine Coalition, a US-based healthcare organization, reported that the U.S. Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, a significant increase from the six approvals in 2022. This growing trend in personalized medicine is driving the growth of the single-cell analysis transcriptomics market.
Major companies operating in the single cell analysis transcriptomics market are focusing on developing innovative products, such as single cell RNA sequencing kits, to streamline workflows and enable deeper insights into cellular heterogeneity. A single cell RNA sequencing kit is a specialized tool to isolate and analyze gene expression at the individual cell level. It allows researchers to uncover cellular diversity and gain insights into complex biological processes. For instance, in January 2024, Scale Biosciences, a US based biotechnology company specializing in single cell solutions, launched the Single Cell RNA Kit v1.1 - Extended Throughput, enabling processing of up to 500,000 cells per run under an instrument free workflow. This release significantly enhances scaling, multiplexing, and cost efficiency in transcriptomic studies.
In May 2024, Bruker Corporation, a US-based manufacturer of scientific instruments, acquired NanoString Technologies for approximately $392.6 million. This acquisition aims to integrate NanoString’s gene expression profiling and spatial transcriptomics solutions into Bruker’s expanding spatial biology portfolio. The integration of NanoString’s technology will enhance Bruker’s capabilities in discovery and translational research, positioning them as a leader in single-cell and spatial biology innovations.
Major companies operating in the single-cell analysis transcriptomics market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius Aktiengesellschaft, Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Abcam Limited, Novogene Co. Ltd., Standard BioTools Inc., Akoya Biosciences Inc., Parse Biosciences Inc., Cell Microsystems Inc., Mission Bio Inc., CYTENA GmbH, Fluent BioSciences.
North America was the largest region in the single-cell analysis transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single-cell analysis transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the single-cell analysis transcriptomics market by increasing the cost of imported sequencing equipment, reagents, and microfluidics consumables. Segments such as RNA sequencers, library preparation kits, and microarray instruments are most impacted, particularly in Asia-Pacific regions like China and India that are major import hubs. This has led to higher operational costs and supply chain challenges. On the positive side, tariffs have encouraged local manufacturing, alternative sourcing strategies, and innovation in cost-effective technologies for transcriptomics research.
The single-cell analysis transcriptomics market research report is one of a series of new reports that provides single-cell analysis transcriptomics market statistics, including single-cell analysis transcriptomics industry global market size, regional shares, competitors with a single-cell analysis transcriptomics market share, detailed single-cell analysis transcriptomics market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell analysis transcriptomics industry. This single-cell analysis transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Single-cell transcriptomics is a powerful technique that enables the study of gene expression at the individual cell level. It helps identify cellular heterogeneity and unique transcriptional profiles within complex tissues. This approach allows researchers to uncover cellular diversity, discover rare cell types, trace developmental lineages, and gain deeper insights into disease mechanisms.
The main component types of single-cell transcriptomics include equipment, consumables, software, and services. In single-cell transcriptomics, equipment is used for precise RNA analysis at the individual cell level, advancing genomic research and personalized medicine. Various technologies, such as single-cell RNA sequencing, microfluidics-based techniques, and others, are employed for applications including clinical diagnostics, developmental biology, drug discovery, and more. These tools are used by a wide range of end-users, including academic and research institutions, hospitals and diagnostic centers, and pharmaceutical and biotechnology companies.
The single-cell analysis transcriptomics market consists of revenues earned by entities by providing services such as data analysis and interpretation, sample preparation, and customized gene expression profiling solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The single-cell analysis transcriptomics market includes sales of RNA extraction kits, library preparation kits, cnd DNA synthesis kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Single-Cell Analysis Transcriptomics Market Characteristics
3. Single-Cell Analysis Transcriptomics Market Supply Chain Analysis
4. Global Single-Cell Analysis Transcriptomics Market Trends and Strategies
5. Single-Cell Analysis Transcriptomics Market Analysis of End Use Industries
7. Global Single-Cell Analysis Transcriptomics Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Single-Cell Analysis Transcriptomics Total Addressable Market (TAM) Analysis for the Market
9. Single-Cell Analysis Transcriptomics Market Segmentation
10. Single-Cell Analysis Transcriptomics Market Regional and Country Analysis
11. Asia-Pacific Single-Cell Analysis Transcriptomics Market
12. China Single-Cell Analysis Transcriptomics Market
13. India Single-Cell Analysis Transcriptomics Market
14. Japan Single-Cell Analysis Transcriptomics Market
15. Australia Single-Cell Analysis Transcriptomics Market
16. Indonesia Single-Cell Analysis Transcriptomics Market
17. South Korea Single-Cell Analysis Transcriptomics Market
18. Taiwan Single-Cell Analysis Transcriptomics Market
19. South East Asia Single-Cell Analysis Transcriptomics Market
20. Western Europe Single-Cell Analysis Transcriptomics Market
21. UK Single-Cell Analysis Transcriptomics Market
22. Germany Single-Cell Analysis Transcriptomics Market
23. France Single-Cell Analysis Transcriptomics Market
24. Italy Single-Cell Analysis Transcriptomics Market
25. Spain Single-Cell Analysis Transcriptomics Market
26. Eastern Europe Single-Cell Analysis Transcriptomics Market
27. Russia Single-Cell Analysis Transcriptomics Market
28. North America Single-Cell Analysis Transcriptomics Market
29. USA Single-Cell Analysis Transcriptomics Market
30. Canada Single-Cell Analysis Transcriptomics Market
31. South America Single-Cell Analysis Transcriptomics Market
32. Brazil Single-Cell Analysis Transcriptomics Market
33. Middle East Single-Cell Analysis Transcriptomics Market
34. Africa Single-Cell Analysis Transcriptomics Market
36. Single-Cell Analysis Transcriptomics Market Competitive Landscape and Company Profiles
37. Single-Cell Analysis Transcriptomics Market Other Major and Innovative Companies
40. Single-Cell Analysis Transcriptomics Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Single-Cell Analysis Transcriptomics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses single-cell analysis transcriptomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for single-cell analysis transcriptomics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single-cell analysis transcriptomics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Equipment; Consumables; Software And Services2) By Technology: Single-Cell Ribonucleic Acid (RNA) Sequencing; Microfluidics-Based Techniques; Other Technologies
3) By Application: Clinical Diagonstics; Developmental Biology; Drug Discovery; Other Applications
4) By End-User: Academic And Research Institutions; Hospitals And Diagonstic Centers; Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Equipment: Ribonucleic Acid (RNA) Sequencers; Polymerase Chain Reaction (PCR) Machines; Microarray Instruments; Electrophoresis Systems; Flow Cytometers; Imaging Systems2) By Consumables: Reagents And Kits; Ribonucleic Acid (RNA) Extraction Kits; Microarray Chips; Sequencing Chips; Complementary DNA (cDNA) Synthesis Kits; Library Preparation Kits; Enzymes And Buffers
3) By Software And Services: Data Analysis Software; Transcriptome Assembly Software; Cloud-Based Solutions; Bioinformatics Services; Data Management Tools; Custom Analysis Services; Technical Support And Training
Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton Dickinson and Company; Agilent Technologies Inc.; Sartorius Aktiengesellschaft; Illumina Inc.; Bio-Rad Laboratories Inc.; Bruker Corporation; QIAGEN N.V.; 10x Genomics Inc.; Abcam Limited; Novogene Co. Ltd.; Standard BioTools Inc.; Akoya Biosciences Inc.; Parse Biosciences Inc.; Cell Microsystems Inc.; Mission Bio Inc.; CYTENA GmbH; Fluent BioSciences
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Single-Cell Analysis Transcriptomics market report include:- Merck KGaA
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Becton Dickinson and Company
- Agilent Technologies Inc.
- Sartorius Aktiengesellschaft
- Illumina Inc.
- Bio-Rad Laboratories Inc.
- Bruker Corporation
- QIAGEN N.V.
- 10x Genomics Inc.
- Abcam Limited
- Novogene Co. Ltd.
- Standard BioTools Inc.
- Akoya Biosciences Inc.
- Parse Biosciences Inc.
- Cell Microsystems Inc.
- Mission Bio Inc.
- CYTENA GmbH
- Fluent BioSciences
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.22 Billion |
| Forecasted Market Value ( USD | $ 1.92 Billion |
| Compound Annual Growth Rate | 12.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
